A novel measure of geographic atrophy shows a stronger correlation with vision loss than the area of the lesion and could aid ...

Aflibercept, bevacizumab, and ranibizumab all improve vision in eyes with center-involved diabetic macular edema, according to a randomized clinical trial. The relative effect of the three drugs ...

Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ® ...

Visual acuity outcomes are comparable in diabetic macular oedema patients who receive laser treatment 24 weeks or more after initiation of ranibizumab injections and those for whom laser therapy is ...

Please provide your email address to receive an email when new articles are posted on . Dyop and ETDRS results were comparable under photopic conditions. However, Dyop results were worse under mesopic ...